ストックスクリーナーアプリを入手
7.69
1.99%
0.15
アフターアワーズ：
7.69
前日終値:
$7.54
開ける：
$7.6
24時間の取引高:
61,239
Relative Volume:
0.54
時価総額：
$740.65M
収益：
$106.66M
当期純損益:
$15.16M
株価収益率:
82.25
EPS:
0.0935
ネットキャッシュフロー:
$6.37M
1週間 パフォーマンス:
-5.30%
1か月 パフォーマンス:
-2.04%
6か月 パフォーマンス:
-10.27%
1年 パフォーマンス:
-44.56%
1日の値動き範囲:
$7.49
$7.735
1週間の範囲:
$7.49
$8.2822
52週間の値動き範囲:
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
名前
Gyre Therapeutics Inc
セクター
電話
(619) 949-3681
住所
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
GYRE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
7.69 | 684.83M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-26 | 開始されました | H.C. Wainwright | Buy |
| 2025-03-11 | 開始されました | Noble Capital Markets | Outperform |
| 2021-04-29 | 再開されました | Stephens | Overweight |
| 2021-02-10 | 開始されました | Piper Sandler | Overweight |
| 2020-05-21 | 開始されました | Raymond James | Outperform |
| 2019-01-04 | 開始されました | Oppenheimer | Outperform |
| 2018-02-12 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-12-08 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | 開始されました | Chardan Capital Markets | Buy |
| 2017-06-06 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-06-30 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
Gyre Therapeutics Inc (GYRE) 最新ニュース
Can momentum traders help lift Gyre Therapeutics Inc.Buy Signal & Community Verified Trade Alerts - newser.com
Highs Report: Will Gyre Therapeutics Inc outperform tech stocksMarket Risk Analysis & Verified Stock Trade Ideas - خودرو بانک
Fundamentals Check: Is Gyre Therapeutics Inc currently under institutional pressureJuly 2025 PreEarnings & Community Consensus Picks - خودرو بانک
Sentiment Recap: What drives Gyre Therapeutics Inc.’s stock priceTrend Reversal & Growth Focused Investment Plans - خودرو بانک
Patterns Watch: What dividend growth rate does Gyre Therapeutics Inc offerJuly 2025 Review & Community Trade Idea Sharing Platform - خودرو بانک
Retail Trends: Is Salarius Pharmaceuticals Inc currently under institutional pressure2025 Short Interest & Weekly Top Performers Watchlists - خودرو بانک
Can Gyre Therapeutics Inc. stock outperform in a bear marketJuly 2025 Drop Watch & Daily Price Action Insights - خودرو بانک
Earnings Report: Does PLUR stock benefit from AI growthQuarterly Portfolio Report & Smart Allocation Stock Tips - خودرو بانک
Does Gyre Therapeutics Inc. qualify in momentum factor screeningQuarterly Portfolio Summary & High Accuracy Buy Signal Tips - newser.com
Can Gyre Therapeutics Inc expand into new marketsMarket Risk Report & Intraday High Probability Alerts - خودرو بانک
Using economic indicators to assess Gyre Therapeutics Inc. potentialWeekly Trade Review & Daily Chart Pattern Signals - newser.com
Gyre Therapeutics Inc. stock outlook for YEARProduct Launch & Low Risk Investment Opportunities - newser.com
Aug Fed Impact: What are CLVTs recent SEC filings showingJuly 2025 Pullbacks & Accurate Entry/Exit Alerts - خودرو بانک
Short Squeeze: Will Gyre Therapeutics Inc stock hit new highs in YEAREarnings Growth Summary & Verified Swing Trading Watchlists - خودرو بانک
Earnings Report: Can Gyre Therapeutics Inc weather a recessionJuly 2025 Chart Watch & AI Based Trade Execution Alerts - خودرو بانک
Retail Surge: Can Gyre Therapeutics Inc expand into new marketsTrade Risk Assessment & Community Verified Trade Alerts - خودرو بانک
Is Gyre Therapeutics Inc. forming a reversal patternQuarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Analyst Downgrade: Is Gyre Therapeutics Inc. stock a value trapQuarterly Earnings Summary & Technical Confirmation Trade Alerts - خودرو بانک
Chart based analysis of Gyre Therapeutics Inc. trendsPortfolio Update Report & Verified Momentum Watchlists - newser.com
Trend Report: Is Gyre Therapeutics Inc benefiting from innovation trendsPortfolio Update Summary & Fast Momentum Stock Entry Tips - خودرو بانک
What is Noble Financial's Forecast for GYRE Q3 Earnings? - MarketBeat
What is Noble Financial's Estimate for GYRE Q1 Earnings? - MarketBeat
Does Gyre Therapeutics Inc have declining or rising EPSJuly 2025 Chart Watch & Low Risk Entry Point Guides - خودرو بانک
Is Gyre Therapeutics Inc benefiting from innovation trendsQuarterly Profit Summary & Expert Approved Trade Ideas - خودرو بانک
Short Covering: Can Gyre Therapeutics Inc. sustain its profitabilityEntry Point & Safe Capital Growth Stock Tips - خودرو بانک
Fundamentals Check: Can Gyre Therapeutics Inc scale operations efficientlyJuly 2025 Decliners & AI Driven Price Forecasts - خودرو بانک
Multi factor analysis applied to Gyre Therapeutics Inc.Bear Alert & Safe Capital Growth Stock Tips - newser.com
Hedge Fund Moves: Is Gyre Therapeutics Inc. a defensive stockJuly 2025 Levels & Real-Time Volume Spike Alerts - خودرو بانک
Breakout Move: Does Gyre Therapeutics Inc offer margin of safetyGap Up & Real-Time Volume Triggers - خودرو بانک
Comparing Gyre Therapeutics (NASDAQ:GYRE) & ABVC BioPharma (NASDAQ:ABVC) - Defense World
Key resistance and support levels for Gyre Therapeutics Inc.Earnings Growth Report & Safe Entry Zone Identification - newser.com
Will Gyre Therapeutics Inc. bounce back from current supportFed Meeting & Reliable Price Breakout Signals - Newser
Evaluating Gyre Therapeutics Inc. with trendline analysisJuly 2025 Highlights & Technical Entry and Exit Alerts - Newser
how high can gyre therapeutics inc. stock goMarket Risk Summary & Long-Term Capital Growth Ideas - Newser
How to use Fibonacci retracement on Gyre Therapeutics Inc.2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Is it time to cut losses on Gyre Therapeutics Inc.July 2025 Short Interest & Low Risk Growth Stock Ideas - Newser
How high can Gyre Therapeutics Inc. stock goWeekly Trade Review & Community Consensus Stock Picks - Newser
Full technical analysis of Gyre Therapeutics Inc. stock2025 Year in Review & Verified Stock Trade Ideas - Newser
Gyre Therapeutics Inc. stock prediction for this weekMarket Sentiment Report & Technical Analysis for Trade Confirmation - Newser
What earnings revisions data tells us about Gyre Therapeutics Inc.Portfolio Value Report & Stock Portfolio Risk Control - Newser
Multi asset correlation models including Gyre Therapeutics Inc.Weekly Investment Report & Weekly Top Gainers Alerts - Newser
Gyre Therapeutics Inc. stock volume spike explainedJuly 2025 Analyst Calls & Free Daily Entry Point Trade Alerts - Newser
Can machine learning forecast Gyre Therapeutics Inc. recoveryPortfolio Risk Summary & Reliable Entry Point Trade Alerts - Newser
Intraday pattern recognizer results for Gyre Therapeutics Inc.2025 Trading Recap & Daily Entry Point Trade Alerts - Newser
Gyre Therapeutics Inc (GYRE) 財務データ
収益
当期純利益
現金流量
EPS
Gyre Therapeutics Inc (GYRE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Ma Songjiang | President |
May 28 '25 |
Sale |
10.07 |
558 |
5,619 |
2,806,084 |
| Ma Songjiang | President |
May 22 '25 |
Sale |
10.97 |
2,000 |
21,940 |
2,808,824 |
| Ma Songjiang | President |
May 23 '25 |
Sale |
10.24 |
182 |
1,864 |
2,808,642 |
| Ma Songjiang | President |
May 20 '25 |
Sale |
11.25 |
2,000 |
22,500 |
2,812,824 |
| Ma Songjiang | President |
May 21 '25 |
Sale |
10.83 |
2,000 |
21,660 |
2,810,824 |
| Ma Songjiang | President |
May 16 '25 |
Sale |
11.31 |
2,000 |
22,620 |
2,816,824 |
| Ma Songjiang | President |
May 19 '25 |
Sale |
11.11 |
2,000 |
22,220 |
2,814,824 |
| Ma Songjiang | President |
May 15 '25 |
Sale |
10.68 |
2,000 |
21,360 |
2,818,824 |
| Ma Songjiang | President |
May 14 '25 |
Sale |
11.30 |
20 |
226 |
2,820,824 |
| Ye Weiguo | Chief Operating Officer |
Apr 01 '25 |
Option Exercise |
0.75 |
50,000 |
37,500 |
700,000 |
0.25%
0.14%
大文字化:
|
ボリューム (24 時間):